CorVel Corporation

What they do

CorVel provides claims management, bill review, preferred provider networks, utilization management, case management, pharmacy, directed care and Medicare services to insurers, third-party administrators, government entities and self-insured employers. It delivers these as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons. The company was incorporated in Delaware in 1987 and is headquartered in Fort Worth, Texas, with a nationwide branch network.

Revenue drivers

• Patient Management Services — Includes claims management and all services sold to claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation and life care planning. Offered standalone or integrated with medical cost containment services, and includes claims processing for self-insured property and casualty payors.
• Network Solutions Services — Designed to reduce prices paid for medical services in workers' compensation, auto and group health cases. Includes automated medical fee auditing, preferred provider management, retrospective utilization review, facility and professional review, pharmacy services, Medicare solutions, clearinghouse services and inpatient bill review.
• CareIQ directed care network — Revenue from CorVel's directed care network, covering imaging, physical therapy, durable medical equipment, translation and transportation as part of Network Solutions.

Recent performance

For the quarter ended June 30, 2026, revenues were $260 million, up 11% from $235 million in the June 2025 quarter. Gross profit rose 19% to $67.8 million at a 26% gross margin, from $56.8 million a year earlier. Diluted earnings per share were $0.63, up 21% from $0.52. The company ended the quarter with $256 million of cash, cash equivalents and no borrowings, and repurchased $21.8 million of common stock during the quarter.

Strategy

CorVel combines integrated technology, including artificial intelligence, machine learning and natural language processing, with human claims-management expertise. It emphasizes a nationwide branch network delivering locally customized services with national support. In the quarter it introduced Executive Advisory Services for workers' compensation and liability clients, combining operational expertise, analytics, benchmarking and technology. CERIS broadened payment integrity capabilities through new client implementations and targeted investments aimed at improving payment accuracy and helping health plans address cost and regulatory pressure. During fiscal 2026 the company spent $56.2 million to repurchase 782,744 shares under its Board-approved program.

Risks

• Sequential revenue may not increase — CorVel states its sequential revenue growth may not increase and may decline, and that falling below investor or analyst expectations could cause the stock price to decline substantially.
• Declining workers' compensation claims — The company cites a decreasing number of national claims based on the number of injured workers, a flat-to-declining workers' compensation market and considerable price competition as factors making revenue and margin growth harder.
• Competition from larger-resourced rivals — CorVel states its technology and preferred provider network face competition from companies with more resources available to them.
• Regulatory and legislative change — Changes or potential changes in state workers' compensation and automobile-managed care laws, and governmental or public policy changes, can reduce demand for the company's services.

Outlook

CorVel remains focused on delivering measurable value across both Patient Management and Network Solutions by combining operational expertise with technology and data-driven insights. Management cites the introduction of Executive Advisory Services and CERIS payment integrity investments as recent efforts to reduce costs and improve program performance for clients. The company reported no borrowings and $256 million of cash at June 30, 2026. It does not provide specific forward financial guidance in the materials reviewed.